Dundee University researches have been busy researching Protease inhibitors and have recently filed patent on their last research. Protease inhibitors are agents that can stop splitting a protein into peptides and are used primarily in HIV/AIDS treatment.
The Dundee researchers state "Based on their importance in health and disease, the proteases of the endo-lysosomal pathway - particularly the cathepsins - have frequently been proposed as therapeutic targets. Effective pharmaceutical exploitation of the pathway has been prevented by the issue of redundancy - novel methods to overcome this challenge are required."